drugset
drugset / Trial / NCT02413502

Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US

NCT02413502 ↗

Phase 0 Completed 10 enrolled Aeras University of Rochester · collab
NaSingle-groupOpen-labelBasic science

Summary

The objective of this protocol is to obtain biological samples through leukapheresis and cryopreservation of cells for the future study, by in vitro assay, of immune responses after one dose of BCG in BCG-naïve healthy adults.

Timeline

Start
2015-05
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Background BCG Tice Vaccine — Other

Indications

tuberculosis